Cargando…
Heterogeneity of Rabies Vaccination Recommendations across Asia
Asian countries bear the greatest burden of the disease, with a majority (59%) of rabies-related deaths occurring in Asia. In order to promote best practices, we summarized national human vaccination guidelines across this region, to highlight differences and similarities and to discuss the aspects...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082101/ https://www.ncbi.nlm.nih.gov/pubmed/30270882 http://dx.doi.org/10.3390/tropicalmed2030023 |
_version_ | 1783345765045764096 |
---|---|
author | Buchy, Philippe Preiss, Scott Singh, Ved Mukherjee, Piyali |
author_facet | Buchy, Philippe Preiss, Scott Singh, Ved Mukherjee, Piyali |
author_sort | Buchy, Philippe |
collection | PubMed |
description | Asian countries bear the greatest burden of the disease, with a majority (59%) of rabies-related deaths occurring in Asia. In order to promote best practices, we summarized national human vaccination guidelines across this region, to highlight differences and similarities and to discuss the aspects that would benefit from updates. National management guidelines for rabies were retrieved from various sources to extract information on rabies pre- and post-exposure prophylaxis (PrEP, and PEP), booster vaccination, and route of administration. Rabies guidelines recommendations for wound management and PrEP across Asia are broadly aligned to the World Health Organization (WHO) guidelines. For PEP, the 5-dose Essen, and the 4-dose Zagreb are the regimens of choice for intramuscular (IM), and the Thai Red Cross regimen for intradermal (ID), administration. Several national guidelines have yet to endorse ID vaccine administration. Most guidelines recommend rabies immunoglobulin in category III exposures. Booster recommendations are not included in all guidelines, with limited clarity on booster requirement across the spectrum of risk of rabies exposure. In conclusion, national recommendations across Asian countries differ and while some guidelines are closely aligned to the WHO recommendations, resource-saving ID administration and use of rational abbreviated schedules have yet to be endorsed. |
format | Online Article Text |
id | pubmed-6082101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60821012018-09-24 Heterogeneity of Rabies Vaccination Recommendations across Asia Buchy, Philippe Preiss, Scott Singh, Ved Mukherjee, Piyali Trop Med Infect Dis Review Asian countries bear the greatest burden of the disease, with a majority (59%) of rabies-related deaths occurring in Asia. In order to promote best practices, we summarized national human vaccination guidelines across this region, to highlight differences and similarities and to discuss the aspects that would benefit from updates. National management guidelines for rabies were retrieved from various sources to extract information on rabies pre- and post-exposure prophylaxis (PrEP, and PEP), booster vaccination, and route of administration. Rabies guidelines recommendations for wound management and PrEP across Asia are broadly aligned to the World Health Organization (WHO) guidelines. For PEP, the 5-dose Essen, and the 4-dose Zagreb are the regimens of choice for intramuscular (IM), and the Thai Red Cross regimen for intradermal (ID), administration. Several national guidelines have yet to endorse ID vaccine administration. Most guidelines recommend rabies immunoglobulin in category III exposures. Booster recommendations are not included in all guidelines, with limited clarity on booster requirement across the spectrum of risk of rabies exposure. In conclusion, national recommendations across Asian countries differ and while some guidelines are closely aligned to the WHO recommendations, resource-saving ID administration and use of rational abbreviated schedules have yet to be endorsed. MDPI 2017-07-06 /pmc/articles/PMC6082101/ /pubmed/30270882 http://dx.doi.org/10.3390/tropicalmed2030023 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Buchy, Philippe Preiss, Scott Singh, Ved Mukherjee, Piyali Heterogeneity of Rabies Vaccination Recommendations across Asia |
title | Heterogeneity of Rabies Vaccination Recommendations across Asia |
title_full | Heterogeneity of Rabies Vaccination Recommendations across Asia |
title_fullStr | Heterogeneity of Rabies Vaccination Recommendations across Asia |
title_full_unstemmed | Heterogeneity of Rabies Vaccination Recommendations across Asia |
title_short | Heterogeneity of Rabies Vaccination Recommendations across Asia |
title_sort | heterogeneity of rabies vaccination recommendations across asia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082101/ https://www.ncbi.nlm.nih.gov/pubmed/30270882 http://dx.doi.org/10.3390/tropicalmed2030023 |
work_keys_str_mv | AT buchyphilippe heterogeneityofrabiesvaccinationrecommendationsacrossasia AT preissscott heterogeneityofrabiesvaccinationrecommendationsacrossasia AT singhved heterogeneityofrabiesvaccinationrecommendationsacrossasia AT mukherjeepiyali heterogeneityofrabiesvaccinationrecommendationsacrossasia |